| Type | Title | Date Released | |
|---|---|---|---|
8-K | Parabilis Medicines Enters into Third Amendment of Lease for Cambridge Headquarters and Expansion | ||
8-K | Parabilis Medicines to Present Updated Clinical Data for Zolucatetide at ESMO Congress 2026 | ||
8-K | Parabilis Medicines, Inc. Announces Departure of Chief Medical Officer | ||
4 | Tendler Craig (Reporting) | ||
3 | Tendler Craig (Reporting) | ||
8-K | Parabilis Medicines Appoints Oncology Drug Development Leader Craig L. Tendler, M.D., to Board of Directors | ||
SCHEDULE 13G | ARCH Venture Fund XII, L.P. (Filed by) | ||
10-Q | Form 10-Q | ||
8-K | Parabilis Medicines Reports Q2 2026 Financial Results and Business Updates | ||
SCHEDULE 13G | FMR LLC (Filed by) | ||
4 | RA Capital Healthcare Fund LP (Reporting) | ||
4 | Soleus Capital, LLC (Reporting) |
